BR9812923A - Composição para controle de colonização/ crescimento bacteriano, e, processos para controle de colonização bacteriana, para formação de uma composição para controle de proliferação de colÈnias bacterianas e para controle de colonização de placa bacteriana dentro de cavidade oral - Google Patents

Composição para controle de colonização/ crescimento bacteriano, e, processos para controle de colonização bacteriana, para formação de uma composição para controle de proliferação de colÈnias bacterianas e para controle de colonização de placa bacteriana dentro de cavidade oral

Info

Publication number
BR9812923A
BR9812923A BR9812923-6A BR9812923A BR9812923A BR 9812923 A BR9812923 A BR 9812923A BR 9812923 A BR9812923 A BR 9812923A BR 9812923 A BR9812923 A BR 9812923A
Authority
BR
Brazil
Prior art keywords
bacterial
controlling
colonization
composition
control
Prior art date
Application number
BR9812923-6A
Other languages
English (en)
Inventor
John A Budny
Original Assignee
Pharmacal Biotechnologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacal Biotechnologies Inc filed Critical Pharmacal Biotechnologies Inc
Publication of BR9812923A publication Critical patent/BR9812923A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/66—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/57—Compounds covalently linked to a(n inert) carrier molecule, e.g. conjugates, pro-fragrances
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Birds (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)

Abstract

"COMPOSIçãO PARA CONTROLE DE COLONIZAçãO/CRESCIMENTO BACTERIANO, E, PROCESSOS PARA CONTROLE DE COLONIZAçãO BACTERIANA, PARA FORMAçãO DE UMA COMPOSIçãO PARA CONTROLE DE PROLIFERAçãO DE COLÈNIAS BACTERIANAS E PARA CONTROLE DE COLONIZAçãO DE PLACA BACTERIANA DENTRO DE CAVIDADE ORAL" Uma composição para controlar o crescimento/a colonização bacteriana é descrita. A composição compreende uma enzima, uma molécula âncora acoplada na enzima para formar um complexo de âncora-enzima, com a âncora sendo capaz de ligar um substrato próximo a uma colónia bacteriana. A ligação no substrato permite tempo de retenção prolongado do complexo de âncora-enzima no qual a colónia bacteriana está presente para aumentar a efetividade do complexo. A invenção também refere-se a um processo de controle de colonização de placa bacteriana na cavidade oral, bem como a um processo de formação de uma composição para controle da proliferação de colónias bacterianas na cavidade oral.
BR9812923-6A 1997-10-16 1998-10-13 Composição para controle de colonização/ crescimento bacteriano, e, processos para controle de colonização bacteriana, para formação de uma composição para controle de proliferação de colÈnias bacterianas e para controle de colonização de placa bacteriana dentro de cavidade oral BR9812923A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/951,393 US5871714A (en) 1997-10-16 1997-10-16 Compositions for controlling bacterial colonization
PCT/US1998/021656 WO1999018999A1 (en) 1997-10-16 1998-10-13 Compositions for controlling bacterial colonization

Publications (1)

Publication Number Publication Date
BR9812923A true BR9812923A (pt) 2000-08-08

Family

ID=25491643

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9812923-6A BR9812923A (pt) 1997-10-16 1998-10-13 Composição para controle de colonização/ crescimento bacteriano, e, processos para controle de colonização bacteriana, para formação de uma composição para controle de proliferação de colÈnias bacterianas e para controle de colonização de placa bacteriana dentro de cavidade oral

Country Status (22)

Country Link
US (1) US5871714A (pt)
EP (1) EP1023084A1 (pt)
JP (1) JP2001519404A (pt)
KR (1) KR20010015757A (pt)
CN (1) CN1276732A (pt)
AU (1) AU742762B2 (pt)
BR (1) BR9812923A (pt)
CA (1) CA2306459A1 (pt)
CU (1) CU22838A3 (pt)
CZ (1) CZ20001237A3 (pt)
EA (1) EA002244B1 (pt)
HU (1) HUP0100016A2 (pt)
ID (1) ID24368A (pt)
IL (1) IL135628A0 (pt)
IN (1) IN2002DE00891A (pt)
MX (1) MXPA00003618A (pt)
NO (1) NO20001885L (pt)
NZ (1) NZ503974A (pt)
PL (1) PL339900A1 (pt)
TR (1) TR200000988T2 (pt)
WO (1) WO1999018999A1 (pt)
ZA (1) ZA989024B (pt)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6830745B1 (en) * 1997-10-16 2004-12-14 Pharmacal Biotechnologies, Llc Compositions for treating biofilm
US6159447A (en) * 1997-10-16 2000-12-12 Pharmacal Biotechnologies, Llc Compositions for controlling bacterial colonization
US20020022005A1 (en) * 1997-10-16 2002-02-21 Budny John A. Compositions for treating cystic fibrosis
US5972311A (en) * 1998-01-26 1999-10-26 Duke University Method of preventing dental caries and other oral lesions
DE19909770A1 (de) 1999-03-05 2000-09-07 Werner Lubitz Bakterienghosts als Träger- und Targetingvehikel
US10810355B1 (en) 2001-07-16 2020-10-20 Clantech, Inc. Allowing operating system access to non-standard fonts in a network document
US8522127B2 (en) 2001-07-16 2013-08-27 Robert G. Adamson, III Allowing operating system access to non-standard fonts in a network document
US20050014932A1 (en) * 2003-05-15 2005-01-20 Iogenetics, Llc Targeted biocides
US8703134B2 (en) 2003-05-15 2014-04-22 Iogenetics, Llc Targeted cryptosporidium biocides
US7566447B2 (en) * 2003-05-15 2009-07-28 Iogenetics, Llc Biocides
US8394379B2 (en) * 2003-05-15 2013-03-12 Iogenetics, Llc Targeted cryptosporidium biocides
US7220405B2 (en) * 2003-09-08 2007-05-22 E. I. Du Pont De Nemours And Company Peptide-based conditioners and colorants for hair, skin, and nails
US20080274095A1 (en) * 2004-10-20 2008-11-06 Jane Homan Biocides
MX2009005783A (es) * 2006-12-01 2009-10-28 Laclede Inc Uso de enzimas hidroliticas y oxidativas para disolver bio-peliculas en los oidos.
WO2009014907A1 (en) 2007-07-25 2009-01-29 3M Innovative Properties Company Therapeutic dental composition and related methods
JP5453260B2 (ja) * 2007-07-25 2014-03-26 スリーエム イノベイティブ プロパティズ カンパニー 被膜形成歯科用組成物及び関連する方法
EP2092834A1 (en) * 2008-02-19 2009-08-26 Innopact B.V. Methods and compositions of sphingolipid for preventing treating microbial infections
AU2011349447A1 (en) 2010-12-20 2013-05-30 E. I. Du Pont De Nemours And Company Targeted perhydrolases
AU2011349451A1 (en) 2010-12-20 2013-05-30 E. I. Du Pont De Nemours And Company Enzymatic peracid generation for use in oral care products
CN102219597B (zh) * 2011-04-11 2013-09-11 北京中农瑞利源高科技发展有限公司 酶控剂和酶控系列肥料及其在农业中的应用
US20120315260A1 (en) * 2011-06-13 2012-12-13 Svetlana A. Ivanova Compositions and Methods to Prevent and Treat Biofilms
US10420822B2 (en) 2011-06-13 2019-09-24 Ziolase, Llc Compositions and methods to prevent and treat biofilms
US9763881B2 (en) 2012-06-11 2017-09-19 Council Of Scientific And Industrial Research Rice bran-lipids based formulation and process for preparation thereof for selective delivery of genes to cancer cells
KR102360720B1 (ko) * 2015-06-30 2022-02-10 (주)아모레퍼시픽 프라그 기질 용해제
CN111551416B (zh) * 2020-03-22 2021-08-06 华南理工大学 一种基于细胞膜磷脂酰丝氨酸荧光染色的细菌类凋亡评价方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1373487A (en) * 1970-10-26 1974-11-13 Guggenheim B Enzymes their preparation and uses
US4335101A (en) * 1971-08-10 1982-06-15 Merck & Co., Inc. Oral hygiene enzymes and method for preparation
JPS5536317B2 (pt) * 1972-04-22 1980-09-19
GB1433593A (en) * 1972-06-09 1976-04-28 Royal College Of Surgeons Conjugates
US4138476A (en) * 1977-08-03 1979-02-06 The United States Of America As Represented By The Secretary Of The Navy Plaque dispersing enzymes as oral therapeutic agents by molecular alteration
JPS57165312A (en) * 1981-04-03 1982-10-12 Handai Biseibutsubiyou Kenkyukai Production of oral composition
JPH0641424B2 (ja) * 1984-11-06 1994-06-01 ライオン株式会社 う蝕予防剤
US5306639A (en) * 1985-03-20 1994-04-26 Aizo Matsushiro DNA encoding glucanase enzymes
US4737359A (en) * 1985-04-18 1988-04-12 Colgate-Palmolive Company Control of dental plaque and caries using emulsan
GB8528761D0 (en) * 1985-11-22 1985-12-24 Axon Healthcare Ltd Enzyme-coupled antibodies
AU5546090A (en) * 1989-06-30 1991-01-17 Brunswick Corporation Antibody-lactate oxidase conjugates
JPH0363215A (ja) * 1989-07-29 1991-03-19 Nakano Vinegar Co Ltd 歯垢分解組成物
GB9021671D0 (en) * 1990-10-05 1990-11-21 Unilever Plc Delivery of agents
AU642980B2 (en) * 1990-03-21 1993-11-04 Quest International B.V. Ultilization of enzymes
AU642979B2 (en) * 1990-03-21 1993-11-04 Quest International B.V. Utilization and delivery of enzymes
US5202113A (en) * 1990-04-30 1993-04-13 The United States Of America As Represented By The Department Of Health And Human Services Plaque-inhibiting protein from bacteroides loeschei and methods for using the same
US5362480A (en) * 1991-12-31 1994-11-08 Lever Brothers Company, Division Of Conopco, Inc. Oral hygiene compositions containing amino sugars as antiplaque agents
US5409902A (en) * 1991-12-31 1995-04-25 Lever Brothers Company Oral hygiene compositions containing glyceroglycolipids as antiplaque compounds
US5320831A (en) * 1992-12-30 1994-06-14 The Procter & Gamble Company Oral compositions
US5490978A (en) * 1993-10-15 1996-02-13 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Block copolymers of polysaccharides and polyalkylene oxides
EP0824019B1 (en) * 1996-08-13 2002-11-20 Quest International B.V. Inhibition or reduction of oral malodour

Also Published As

Publication number Publication date
NO20001885D0 (no) 2000-04-12
ID24368A (id) 2000-07-13
CA2306459A1 (en) 1999-04-22
AU9802898A (en) 1999-05-03
CZ20001237A3 (cs) 2000-08-16
EP1023084A1 (en) 2000-08-02
IL135628A0 (en) 2001-05-20
US5871714A (en) 1999-02-16
CN1276732A (zh) 2000-12-13
EA002244B1 (ru) 2002-02-28
IN2002DE00891A (pt) 2005-01-21
HUP0100016A2 (hu) 2001-05-28
WO1999018999A1 (en) 1999-04-22
ZA989024B (en) 1999-04-07
KR20010015757A (ko) 2001-02-26
NO20001885L (no) 2000-06-14
CU22838A3 (es) 2006-04-18
TR200000988T2 (tr) 2000-08-21
PL339900A1 (en) 2001-01-15
EA200000422A1 (ru) 2000-10-30
MXPA00003618A (es) 2001-10-01
NZ503974A (en) 2002-05-31
JP2001519404A (ja) 2001-10-23
AU742762B2 (en) 2002-01-10

Similar Documents

Publication Publication Date Title
BR9812923A (pt) Composição para controle de colonização/ crescimento bacteriano, e, processos para controle de colonização bacteriana, para formação de uma composição para controle de proliferação de colÈnias bacterianas e para controle de colonização de placa bacteriana dentro de cavidade oral
ID24398A (id) Metode untuk menghasilkan asam l-amino
BR9813021A (pt) Processo para preparação microbiana de aminoácidos da famìlia do aspartato e/ou glutamato e agente empregável no processo
DE60029566D1 (de) In-vitro herstellung von transplantierbarem knorpelgewebe
AU2001221607A1 (en) Endosseous implant
DE59409542D1 (de) Neue Mikroorganismen, deren Verwendung und Verfahren zur Herstellung von L-Alpha-Aminosäuren
BR0201520A (pt) Método para produzir uma subst ncia de marcação utilizando um microorganismo
BR9609041A (pt) "terapia de substituição para cáries dentais".
SE9801090D0 (sv) New medium and process
BG98761A (en) Substituted pyrroles
ATE312937T1 (de) Verfahren zur herstellung von l-glutaminsäure
AU2002226426A1 (en) Composition and method of creating, regenerating and repairing tissues using a cell-carrying biological implant which is enriched with a platelet concentrate and supplements
DE3887856T2 (de) Methode zur Herstellung von natürlichen, menschlichen Wachstumshormon in reiner Form.
DE69921180D1 (de) Künstliche matrix-anheftungsregion zur erhöhung der expression von in pflanzen eingeführten genen
DE69110906T2 (de) Verwendung von Wirtszellphospholipiden zur Hemmung bakterieller Besiedlung.
BR9910677A (pt) Processo de preparação de ésteres de<244>-fenilalanina substancialmenteenantiomericamente puros e utilização de umaenzima total ou parcialmente purificada de tipoprotease
ATE83480T1 (de) Cyclisches peptid, seine herstellung und seine verwendung zur behandlung von cardiovasculaeren stoerungen.
BR9807144A (pt) Microorganismos com produção acrescida de ácido clavulânico
ATE338140T1 (de) Fructosyl-transferase produzierender mikroorganismus und verfahren zur herstellung von fructooligosacchariden und neofructooligosacchariden unter dessen verwendung
UY24578A1 (es) Derivados de dibenzo-oxazepinas y -dioxepinas utiles como agentes antitumorales
UA70974C2 (uk) Ванкорезміцин (варіанти), штам amycolatopsis виду hil-006734, dsm 12216, що його продукує, та фармацевтична композиція, яка має антибіотичну активність
BR9800928A (pt) Material cosmético, e, processo para preparar o mesmo.
HUP9903899A2 (hu) Eljárás L-aminosavak fermentációs előállítására
DE69132050T2 (de) Zusammensetzungen von wachstumsfaktoren, herstellung und verwendung
DE59603534D1 (de) Mikrobiologisches Verfahren zur Herstellung von heteroaromatischen Carbonsäuren mittels Mikroorganismen der Gattung Alcaligenes

Legal Events

Date Code Title Description
FD5 Application fees: dismissal - article 86 of industrial property law
B08H Application fees: decision cancelled [chapter 8.8 patent gazette]

Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1730 DE 20040302 POR TER SIDO APRESENTADA PAPELETA DE ESCLARECIMENTO.

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1894 DE 24/04/2007.

B15K Others concerning applications: alteration of classification

Ipc: A61K 8/64 (2006.01), A61K 8/66 (2006.0